Alglucosidase
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 271 publications
The Effect of Anti-drug Antibodies on the Bioavailability of Alglucosidase Alfa in Classic Infantile Pompe Disease.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: July 26, 2026
A disease progression model comparing the long-term mobility and respiratory outcomes of adults with late-onset Pompe disease receiving cipaglucosidase alfa plus miglustat versus alglucosidase alfa.
Journal: Journal of comparative effectiveness research
Published: July 15, 2026
Early Cardiac Involvement in Late-Onset Pompe Disease: A Case Report from an Iranian Consanguineous Family.
Journal: Iranian journal of child neurology
Published: July 09, 2026
Clinical and genetic characteristics of infantile-onset Pompe disease and long-term efficacy of enzyme replacement therapy
Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Published: May 14, 2026
Defining the therapeutic corridor of stability in enzyme replacement therapy for Pompe disease: a position statement.
Journal: Orphanet journal of rare diseases
Published: May 11, 2026
Recurrent Reactions to Enzyme Replacement Therapy in Infantile-Onset Pompe Disease: A Case of Immunologic Barriers to Drug Tolerance.
Journal: American journal of medical genetics. Part A
Published: April 07, 2026
Impact of Enzyme Replacement Therapy on Patients with Late Onset Pompe Disease - Real World Data from a Developing Country.
Journal: Indian journal of pediatrics
Published: March 25, 2026
Efficacy and safety of cipaglucosidase alfa plus miglustat in Japanese adults with late-onset Pompe disease: a case series from clinical trials.
Journal: BMJ neurology open
Published: February 27, 2026
Comparing the efficacy of cipaglucosidase alfa plus miglustat with alglucosidase alfa for late-onset Pompe disease: an expanded network meta-analysis utilizing patient-level and aggregate data.
Journal: Journal of comparative effectiveness research
Published: February 27, 2026
Enzyme replacement therapy compared with best supportive care for the treatment of Pompe Disease: a systematic review and network meta-analysis.
Journal: Health technology assessment (Winchester, England)
Published: February 16, 2026
Early enzyme replacement therapy in late-onset Pompe disease diagnosed by newborn screening.
Journal: Molecular genetics and metabolism
Published: January 25, 2026
Last Updated: 11/08/2026